Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations. - Ostrowski M; Jo Y; Hage Chehade C; Ozay ZI; Gebrael G; Sayegh N; Lin E; Srivastava A; Gordhamer A; Ji R; Li H; Mathew Thomas V; et al. (JAMA network open, 2025)